Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01096368
Title Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Children's Oncology Group
Indications

papillary ependymoma

clear cell ependymoma

brain ependymoma

cellular ependymoma

Therapies

Carboplatin + Cyclophosphamide + Vincristine sulfate liposome

Carboplatin + Etoposide + Vincristine sulfate liposome

Cisplatin + Cyclophosphamide + Etoposide

Cisplatin + Cyclophosphamide + Etoposide + Vincristine sulfate liposome

Age Groups: child | adult
Covered Countries USA | CAN


No variant requirements are available.